171 related articles for article (PubMed ID: 33593091)
1. A Multi-Institutional Retrospective Analysis of Oncologic Outcomes for Patients With Locally Advanced Cervical Cancer Undergoing Platinum-Based Adjuvant Chemotherapy After Concurrent Chemoradiotherapy.
Wu N; Su X; Song H; Li Y; Gu F; Sun X; Li X; Cheng G
Cancer Control; 2021; 28():1073274821989307. PubMed ID: 33593091
[TBL] [Abstract][Full Text] [Related]
2. Nomogram for Predicting Survival in Locally Advanced Cervical Cancer with Concurrent Chemoradiotherapy plus or Not Adjuvant Chemotherapy: A Retrospective Analysis Based on 2018 FIGO Staging.
Hua L; Wei M; Feng C; Li S; Wen X; Chen S
Cancer Biother Radiopharm; 2024 Jun; ():. PubMed ID: 38828494
[No Abstract] [Full Text] [Related]
3. Efficacy and safety of different chemotherapy regimens concurrent with radiotherapy in the treatment of locally advanced cervical cancer.
Wu Y; Jiang P; Chen Z; Li W; Dong B; Zhang Y
BMC Cancer; 2024 May; 24(1):589. PubMed ID: 38745137
[TBL] [Abstract][Full Text] [Related]
4. Comparison of outcomes between early-stage cervical cancer patients without high-risk factors undergoing adjuvant concurrent chemoradiotherapy and radiotherapy alone after radical surgery.
Zhou Y; Wang W; Tang J; Hu K; Zhang F
BMC Cancer; 2024 Apr; 24(1):548. PubMed ID: 38689248
[TBL] [Abstract][Full Text] [Related]
5. Neoadjuvant chemotherapy followed by surgery versus concurrent chemoradiotherapy in patients with stage IIB cervical squamous cell carcinoma: a retrospective cohort study.
Pan XB; Lu Y; Wei YS; Yao DS
BMC Cancer; 2024 May; 24(1):655. PubMed ID: 38811880
[TBL] [Abstract][Full Text] [Related]
6. Improving the efficacy and safety of concurrent chemoradiotherapy by neoadjuvant chemotherapy: a randomized controlled study of locally advanced cervical cancer with a large tumor.
Li F; Mei F; Yin S; Du Y; Hu L; Hong W; Li J
J Gynecol Oncol; 2024 Jan; 35(1):e10. PubMed ID: 37857565
[TBL] [Abstract][Full Text] [Related]
7. Evaluating the clinical efficacy and safety of concurrent chemoradiotherapy with cisplatin and nab-paclitaxel in postoperative early-stage cervical cancer.
Zhao N; Li Y; Chen X; Ma J; Luo W; Li Y
J Cancer Res Clin Oncol; 2024 May; 150(5):233. PubMed ID: 38709400
[TBL] [Abstract][Full Text] [Related]
8. Outcomes of concurrent chemoradiotherapy versus chemotherapy alone for advanced-stage unresectable intrahepatic cholangiocarcinoma.
Kim YI; Park JW; Kim BH; Woo SM; Kim TH; Koh YH; Lee WJ; Kim CM
Radiat Oncol; 2013 Dec; 8():292. PubMed ID: 24359879
[TBL] [Abstract][Full Text] [Related]
9. Survival impact of additional chemotherapy after adjuvant concurrent chemoradiation in patients with early cervical cancer who underwent radical hysterectomy.
Kim SI; Kim JY; Wee CW; Lee M; Kim HS; Chung HH; Lee TS; Jeon HW; Park NH; Song YS; Kim TH
BMC Cancer; 2021 Nov; 21(1):1260. PubMed ID: 34809599
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness comparisons of various therapies for FIGO stage IB2/IIA2 cervical cancer: a Bayesian network meta-analysis.
Cheng J; Liu B; Wang B; Long X; Li Z; Chen R; Wu R; Xu L
BMC Cancer; 2021 Oct; 21(1):1078. PubMed ID: 34615494
[TBL] [Abstract][Full Text] [Related]
11. Concurrent weekly nedaplatin, external beam radiotherapy and high-dose-rate brachytherapy in patients with FIGO stage IIIb cervical cancer: a comparison with a cohort treated by radiotherapy alone.
Mabuchi S; Ugaki H; Isohashi F; Yoshioka Y; Temma K; Yada-Hashimoto N; Takeda T; Yamamoto T; Yoshino K; Nakajima R; Kuragaki C; Morishige K; Enomoto T; Inoue T; Kimura T
Gynecol Obstet Invest; 2010; 69(4):224-232. PubMed ID: 20068328
[TBL] [Abstract][Full Text] [Related]
12. Characteristics, treatment patterns, and outcomes in patients with high-risk locally advanced cervical cancer.
Coutinho F; Gokhale M; Doran C; Monberg M; Yamada K; Chen L
Cancer Treat Res Commun; 2024; 39():100800. PubMed ID: 38430610
[TBL] [Abstract][Full Text] [Related]
13. MRI-based volumetric tumor parameters before and during chemoradiation predict tumor recurrence and patient survival in locally advanced cervical cancer: a subgroup analysis of a phase II prospective trial.
Kang HB; Kim SH; Lee JH; Lee HC; Kang NK; Lee JH
Int J Clin Oncol; 2024 May; 29(5):620-628. PubMed ID: 38530569
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of consolidation chemotherapy after adjuvant therapy in stage IB-IIA cervical cancer patients with risk factors: a retrospective single-center study.
Wang J; Guo H; Yang J; Mao J; Wang Y; Gao R; Yan X; Wang J
Front Oncol; 2024; 14():1374195. PubMed ID: 38577338
[TBL] [Abstract][Full Text] [Related]
15. Nomograms for predicting prognostic value of combined neutrophil-to-lymphocyte ratio and SCC-Ag in locally advanced cervical cancer.
Jin L; Cao F; Zhang Y; Dang Y; Wang F
Transl Cancer Res; 2024 Mar; 13(3):1323-1335. PubMed ID: 38617514
[TBL] [Abstract][Full Text] [Related]
16. Nomograms combining computed tomography-based body composition changes with clinical prognostic factors to predict survival in locally advanced cervical cancer patients.
Fu B; Wei L; Wang C; Xiong B; Bo J; Jiang X; Zhang Y; Jia H; Dong J
J Xray Sci Technol; 2024; 32(2):427-441. PubMed ID: 38189735
[TBL] [Abstract][Full Text] [Related]
17. Machine learning-based radiomics for predicting outcomes in cervical cancer patients undergoing concurrent chemoradiotherapy.
Xin W; Rixin S; Linrui L; Zhihui Q; Long L; Yu Z
Comput Biol Med; 2024 May; 177():108593. PubMed ID: 38801795
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of endostar combined with chemoradiotherapy versus chemoradiotherapy alone in locally advanced cervical cancer: A PRISMA-compliant systematic review and meta-analysis.
Maimaitiming N; Ma X; Wei Y; Cao L; Gao Y; Zhang L
Medicine (Baltimore); 2022 Sep; 101(36):e30170. PubMed ID: 36086700
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of bevacizumab in neoadjuvant and concurrent chemoradiotherapy for refractory cervical cancer patients.
Yang H; Huang SG; Dong M; Wang X; He J; Su H; Liu C; Zhu Y; Wei L; Liu Z
Biomol Biomed; 2024 May; ():. PubMed ID: 38761408
[TBL] [Abstract][Full Text] [Related]
20. MRI Plain Scan: A Tool in the Management of Cervical Cancer during Pregnancy.
Gao F; Qian T; Sun M; Lu Y; Cheng J; Fu L
Curr Med Imaging; 2024; 20():1-8. PubMed ID: 38389369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
